Venture Capital
Menlo Park, California, 94025
Since our founding in 1974, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a clinical-stage biopharmaceutical investment firm with approximately $2.7B in assets under management and committed capital.* We invest in both private and public equity of therapeutics-focused companies Our Mission: to improve the lives of patients through science. We strive to provide outstanding results for those we serve: patients, entrepreneurs, and the investors that entrust us with their capital. We team with world class entrepreneurs who want to change life through medicine. With tools and experience to guide them, Sofinnova is helping entrepreneurs challenge the status quo of medical care, advancing cures, and improving lives.
06624sbs
